|
SEPT8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.97840000335259E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96729999957235E-07 |
| Normal-vs-Stage2 |
7.673900E-02 |
| Normal-vs-Stage3 |
4.03020000000476E-05 |
| Normal-vs-Stage4 |
5.370200E-04 |
| Stage1-vs-Stage2 |
2.146800E-01 |
| Stage1-vs-Stage3 |
8.623200E-01 |
| Stage1-vs-Stage4 |
6.509600E-01 |
| Stage2-vs-Stage3 |
2.699600E-01 |
| Stage2-vs-Stage4 |
4.091400E-01 |
| Stage3-vs-Stage4 |
8.144200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.04880004259923E-09 |
| Normal-vs-AfricanAmerican |
7.264100E-03 |
| Normal-vs-Asian |
5.98279999999285E-05 |
| Caucasian-vs-AfricanAmerican |
9.036000E-01 |
| Caucasian-vs-Asian |
5.184000E-01 |
| AfricanAmerican-vs-Asian |
5.618800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.006130E-04 |
| Normal-vs-Female |
6.87529999598979E-08 |
| Male-vs-Female |
4.211600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.49580000005945E-07 |
| Normal-vs-Age(41-60Yrs) |
5.64180000051095E-07 |
| Normal-vs-Age(61-80Yrs) |
1.119560E-02 |
| Normal-vs-Age(81-100Yrs) |
7.653900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.863600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.687500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.954800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.744500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.238200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.830800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.257000E-01 |
| Classical-VS-Follicular |
1.82520665248376E-13 |
| Classical-VS-Other |
3.241000E-01 |
| Classical-VS-Normal |
1.46590517502432E-11 |
| Tall-VS-Follicular |
1.02509999999612E-06 |
| Tall-VS-Other |
2.076400E-01 |
| Tall-VS-Normal |
7.43329999997044E-07 |
| Follicular-VS-Other |
1.447020E-01 |
| Follicular-VS-Normal |
2.729600E-01 |
| Other-VS-Normal |
3.360800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.350200E-04 |
| Normal-vs-N1 |
1.523580E-03 |
| N0-vs-N1 |
3.319600E-01 |
|
|
